TATA Health International Holdings Limited (HKG:1255)
1.740
0.00 (0.00%)
Jan 21, 2026, 2:52 PM HKT
HKG:1255 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 94.26 | 124.46 | 207.54 | 144.61 | 160.93 | 155.36 | Upgrade | |
Revenue Growth (YoY) | -46.36% | -40.03% | 43.52% | -10.14% | 3.58% | -54.54% | Upgrade |
Cost of Revenue | 29.88 | 39.51 | 56.78 | 30.66 | 56.21 | 121.08 | Upgrade |
Gross Profit | 64.38 | 84.95 | 150.76 | 113.94 | 104.72 | 34.28 | Upgrade |
Selling, General & Admin | 124.83 | 125.04 | 180.9 | 144.02 | 162.92 | 183.12 | Upgrade |
Operating Expenses | 139.6 | 139.81 | 185.14 | 144.01 | 162.92 | 182.97 | Upgrade |
Operating Income | -75.22 | -54.86 | -34.38 | -30.06 | -58.2 | -148.69 | Upgrade |
Interest Expense | -4.36 | -4.25 | -1.72 | -2.49 | -2.76 | -3.57 | Upgrade |
Interest & Investment Income | - | - | - | 1.45 | 1.19 | 0.56 | Upgrade |
Earnings From Equity Investments | - | - | -0.21 | -0.4 | -0.57 | 0.78 | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | -0.01 | -0.47 | 0.99 | Upgrade |
Other Non Operating Income (Expenses) | 14.56 | 8.59 | 7.91 | 3.8 | -4.22 | 13.32 | Upgrade |
EBT Excluding Unusual Items | -65.01 | -50.52 | -28.4 | -27.72 | -65.04 | -136.61 | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -3.96 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | -1.51 | - | Upgrade |
Gain (Loss) on Sale of Assets | 34.66 | -5.55 | - | 32.96 | 0.35 | 2.48 | Upgrade |
Asset Writedown | -11.96 | -11.96 | -7.02 | -0.6 | -2.66 | -34.55 | Upgrade |
Other Unusual Items | - | - | - | -0.53 | -0.29 | -0.05 | Upgrade |
Pretax Income | -42.31 | -68.03 | -35.42 | 4.1 | -69.14 | -172.68 | Upgrade |
Income Tax Expense | 0.31 | 0.31 | 0.63 | 0.9 | 1.31 | 0.4 | Upgrade |
Earnings From Continuing Operations | -42.61 | -68.34 | -36.05 | 3.21 | -70.45 | -173.08 | Upgrade |
Minority Interest in Earnings | - | - | 3.75 | 6.41 | 9.69 | 21.21 | Upgrade |
Net Income | -42.61 | -68.34 | -32.29 | 9.61 | -60.76 | -151.87 | Upgrade |
Net Income to Common | -42.61 | -68.34 | -32.29 | 9.61 | -60.76 | -151.87 | Upgrade |
Shares Outstanding (Basic) | 243 | 243 | 243 | 243 | 232 | 214 | Upgrade |
Shares Outstanding (Diluted) | 243 | 243 | 243 | 243 | 232 | 214 | Upgrade |
Shares Change (YoY) | - | - | - | 4.67% | 8.42% | - | Upgrade |
EPS (Basic) | -0.18 | -0.28 | -0.13 | 0.04 | -0.26 | -0.71 | Upgrade |
EPS (Diluted) | -0.18 | -0.28 | -0.13 | 0.04 | -0.26 | -0.71 | Upgrade |
Free Cash Flow | - | - | - | 12.12 | -5.98 | -2.83 | Upgrade |
Free Cash Flow Per Share | - | - | - | 0.05 | -0.03 | -0.01 | Upgrade |
Gross Margin | 68.30% | 68.26% | 72.64% | 78.80% | 65.07% | 22.07% | Upgrade |
Operating Margin | -79.79% | -44.08% | -16.56% | -20.79% | -36.17% | -95.70% | Upgrade |
Profit Margin | -45.20% | -54.91% | -15.56% | 6.65% | -37.76% | -97.75% | Upgrade |
Free Cash Flow Margin | - | - | - | 8.38% | -3.71% | -1.82% | Upgrade |
EBITDA | -62.49 | -39.32 | -33.27 | -28.95 | -56.79 | -146.12 | Upgrade |
EBITDA Margin | -66.29% | -31.60% | -16.03% | -20.02% | -35.29% | -94.05% | Upgrade |
D&A For EBITDA | 12.73 | 15.54 | 1.11 | 1.11 | 1.41 | 2.57 | Upgrade |
EBIT | -75.22 | -54.86 | -34.38 | -30.06 | -58.2 | -148.69 | Upgrade |
EBIT Margin | -79.79% | -44.08% | -16.56% | -20.79% | -36.17% | -95.70% | Upgrade |
Effective Tax Rate | - | - | - | 21.88% | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.